| Name | Lulizumab |
|---|
| Description | Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |